A tailored course, built for your situation
Pragmatic AI in Pharmaceutical R&D Operations for Audit Teams
An implementation-grade course for audit and compliance professionals navigating AI-augmented drug development environments
$199 one-time
24-hour access provisioning
30-day money-back guarantee
Hand-built implementation playbook
12 modules. 12 chapters per module. 144 chapters total.
12 modules, each with 12 chapters (144 chapters total), text-based, plus downloadable templates and a hand-built implementation playbook delivered alongside course access.
Audit teams are being asked to validate AI-driven R&D decisions without clear frameworks, increasing review cycles and compliance exposure.
The situation this course is for
As pharmaceutical companies accelerate AI adoption in clinical trial design, safety monitoring, and regulatory submissions, audit functions lack standardized methods to assess model integrity, data provenance, and change control. This leads to delayed approvals, inconsistent findings, and growing scrutiny from oversight bodies.
Who this is for
Compliance officers, internal auditors, quality assurance leads, and regulatory affairs professionals in biopharma organizations implementing AI in R&D
Who this is not for
This course is not for data scientists building AI models or executives seeking high-level AI strategy overviews.
What you walk away with
- Apply structured audit frameworks to AI-enabled R&D processes
- Evaluate model risk management practices in clinical development pipelines
- Document compliance evidence for AI-augmented decision points
- Navigate FDA and EMA expectations for algorithmic transparency
- Deploy repeatable review templates for AI system validation
The 12 modules (with all 144 chapters)
Module 1. AI in Pharmaceutical R&D: Audit Context
Overview of AI applications in drug discovery, trial design, and regulatory submission with audit relevance.
12 chapters in this module
- Introduction to AI in drug development
- Regulated vs. experimental AI use cases
- Audit scope in AI-driven R&D
- Key regulatory touchpoints
- Stakeholder mapping for AI reviews
- Risk categorization of AI systems
- Defining audit boundaries
- Common failure modes in AI pipelines
- Data flow fundamentals
- Model lifecycle stages
- Change control implications
- Audit timing and cadence
Module 2. Regulatory Landscape for AI in Life Sciences
Current expectations from FDA, EMA, and ICH on AI transparency, validation, and oversight.
12 chapters in this module
- FDA AI/ML Software as a Medical Device guidance
- EMA perspective on algorithmic decision support
- ICH Q9 quality risk management principles
- GxP applicability to AI systems
- ALCOA+ for algorithmic outputs
- Inspection readiness requirements
- Labeling and claims validation
- Post-market surveillance expectations
- Data integrity in AI training sets
- Audit trail requirements for models
- Validation of third-party AI tools
- Documentation standards for regulators
Module 3. Data Governance in AI-Driven R&D
Auditing data provenance, quality, and integrity across AI training and inference stages.
12 chapters in this module
- Data lineage mapping techniques
- Source system validation for AI inputs
- Training vs. operational data drift
- Bias detection in datasets
- Patient data anonymization audits
- Data access and custody logs
- Version control for datasets
- Metadata completeness checks
- External data vendor assessments
- Real-world data integration risks
- Data quality dashboards
- Corrective action tracking
Module 4. Model Risk Management Frameworks
Applying MRB principles to pharmaceutical AI models with audit controls.
12 chapters in this module
- Model risk categorization in R&D
- Independent validation requirements
- Performance threshold setting
- Sensitivity and stability testing
- Model documentation standards
- Versioning and rollback procedures
- Change approval workflows
- Model monitoring in production
- Incident response for model failures
- Third-party model audits
- Vendor oversight for AI platforms
- Model inventory maintenance
Module 5. AI Audit Planning and Scoping
Designing risk-based audit plans for AI systems in clinical and preclinical environments.
12 chapters in this module
- Risk assessment for AI use cases
- Audit universe prioritization
- Resource allocation for technical reviews
- Engaging data science teams
- Defining testing objectives
- Sampling strategies for algorithmic outputs
- Control identification in AI workflows
- Automated testing feasibility
- Audit program development
- Stakeholder communication planning
- Timeline estimation
- Deliverable specifications
Module 6. Testing AI System Controls
Practical methods to test design and operating effectiveness of AI-related controls.
12 chapters in this module
- Control identification in machine learning pipelines
- Design effectiveness testing
- Operating effectiveness validation
- Input validation checks
- Output reconciliation methods
- Exception handling audits
- Boundary condition testing
- Adversarial testing approaches
- Reproducibility verification
- Logging and monitoring coverage
- Alert response validation
- Control gap remediation
Module 7. Algorithmic Transparency and Explainability
Auditing model interpretability and documentation for regulatory defensibility.
12 chapters in this module
- Explainability requirements by use case
- SHAP, LIME, and other XAI methods
- Documentation of feature importance
- Model card reviews
- System cards for AI components
- Stakeholder communication of model logic
- Black box vs. white box trade-offs
- Clinical interpretability standards
- Uncertainty quantification audits
- Decision audit trails
- Human-in-the-loop validation
- Transparency reporting
Module 8. Change Management for AI Systems
Auditing version control, revalidation, and deployment controls in dynamic AI environments.
12 chapters in this module
- Change request documentation
- Impact assessment for model updates
- Revalidation triggers
- Rollback capability testing
- Deployment approval workflows
- Environment segregation checks
- Patch management for AI systems
- Configuration drift audits
- Automated deployment controls
- Post-deployment monitoring
- Change log completeness
- Emergency change oversight
Module 9. Vendor and Third-Party AI Oversight
Auditing external AI tools, cloud platforms, and contract research organizations.
12 chapters in this module
- Vendor risk assessment frameworks
- Due diligence for AI software providers
- Contractual audit rights
- Data processing agreements
- Cloud service provider controls
- API security and monitoring
- Subcontractor oversight
- Performance SLA validation
- Incident reporting requirements
- Access control reviews
- Penetration test result audits
- Exit strategy validation
Module 10. AI in Clinical Trial Operations
Auditing AI applications in patient recruitment, site selection, and endpoint adjudication.
12 chapters in this module
- Patient matching algorithm reviews
- Site feasibility prediction models
- Remote monitoring AI tools
- Adverse event prediction systems
- Endpoint adjudication support
- Informed consent AI assistants
- Data monitoring committee tools
- Trial supply forecasting models
- Protocol deviation prediction
- Patient retention AI
- Centralized monitoring analytics
- Audit implications of decentralized trials
Module 11. AI in Drug Safety and Pharmacovigilance
Auditing signal detection, case processing, and risk management AI systems.
12 chapters in this module
- Adverse event signal detection models
- Natural language processing for case narratives
- Case triage automation
- Literature screening AI
- Signal validation workflows
- Risk management plan modeling
- Benefit-risk assessment tools
- Periodic safety update report automation
- Regulatory submission AI support
- Multilingual case processing
- Duplicate detection algorithms
- Escalation pathway audits
Module 12. Audit Reporting and Regulatory Engagement
Structuring findings, recommendations, and regulatory responses for AI-related audits.
12 chapters in this module
- Finding severity classification
- Technical writing for AI issues
- Evidence packaging for regulators
- Management response tracking
- Corrective action plan reviews
- Regulatory inquiry preparation
- Inspection simulation exercises
- Cross-functional alignment
- Lessons learned documentation
- Trend analysis of AI findings
- Board-level reporting
- Continuous improvement integration
How this maps to your situation
- Auditing AI in early-phase clinical development
- Validating real-world evidence models for regulatory submission
- Assessing third-party AI tools in pharmacovigilance
- Preparing for FDA inspection of algorithmic decision systems
Before vs. after
Before
Audit teams face growing pressure to assess AI systems without standardized frameworks, leading to inconsistent reviews and regulatory uncertainty.
After
Audit professionals confidently apply structured, regulator-aligned methods to validate AI in R&D, producing defensible findings and accelerating compliance cycles.
What's included with your purchase
- 12 modules with 12 chapters each (144 chapters)
- Downloadable templates and worked examples for every module
- Hand-built implementation playbook delivered alongside course access
- 30-day money-back guarantee
Delivery and format
- Course and learning environment access provisioned within 24 hours of purchase
- Hand-built implementation playbook delivered alongside course access
Format: Text-based modules and chapters in the Art of Service learning environment, plus downloadable templates and worked examples for every chapter, plus the hand-built implementation playbook delivered alongside course access.
Time investment: Approximately 60-70 hours of self-paced learning, designed for professionals balancing full-time roles.
If nothing changes
Without structured AI audit practices, organizations risk delayed approvals, regulatory citations, and loss of stakeholder trust due to unvalidated algorithmic decisions in critical R&D processes.
How this compares to the alternatives
Unlike generic AI ethics courses or technical data science programs, this course delivers audit-specific frameworks aligned with current regulatory expectations and real-world pharmaceutical R&D workflows.
Frequently asked
Who is this course designed for?
Compliance officers, internal auditors, quality assurance leads, and regulatory affairs professionals in biopharma organizations implementing AI in R&D.
How is the course structured?
12 modules, each containing 12 chapters (144 chapters total).
Is prior AI experience required?
No. The course builds from foundational concepts to advanced audit techniques, making it accessible to audit professionals new to AI while providing depth for experienced practitioners.
$199 one-time. Approximately 60-70 hours of self-paced learning, designed for professionals balancing full-time roles..
Within 24 hours your account in the learning environment is provisioned and the tailored implementation playbook is delivered alongside it.
30-day money-back guarantee·
144 chapters·
Hand-built playbook included·
Account access within 24 hours